论文部分内容阅读
本文报道了WHO西太区江苏省结核病控制示范项目两年实施总结情况和效果评价。两年来，示范区共接诊13016名可疑肺结核症状者，发现涂阳肺结核病人2356例，其中新发涂阳病人1861例，年平均涂阳新登记率为31．2／10万，新发涂阳登记率为24．6／10万，分别较项目前增长了79．3％和80．9％。初治涂阳病人治愈率为92．9％，复治涂阳病人治愈率为68．9％，而项目前初治涂阳病人平均治愈率为68．1％。每例涂阳病人治疗和管理总成本为1026元，成本效益比为1：28．87。
This article reports the implementation summary and effect evaluation of the TB control demonstration project in the WHO Western Pacific Region in Jiangsu Province in two years. In the past two years, a total of 13,016 cases of suspected tuberculosis were admitted to the demonstration area. A total of 2,356 smear positive pulmonary tuberculosis patients were found, of which 1861 were new smear positive cases, and the annual average smear positive enrollment rate was 31.2 / 100,000. The registration rate was 24.6 / 100,000, up 79.3% and 80.9% respectively over the previous month. The cure rate of newly smear positive patients was 92.9%, the cure rate of smear positive patients was 68.9%, while the average cure rate of smear positive patients before the project was 68.1%. The total cost of treatment and management of smear-positive patients in each case was 1026 yuan, the cost-benefit ratio was 1: 28.87.